Polyethylene Glycol-3350 and Electrolytes with Flavor Pack (Novel Laboratories, Inc.)


Welcome to the PulseAid listing for the Polyethylene Glycol-3350 and Electrolytes with Flavor Pack drug offered from Novel Laboratories, Inc.. This Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Novel Laboratories, Inc.
NON-PROPRIETARY NAME: Polyethylene Glycol-3350 and Electrolytes with Flavor Pack
SUBSTANCE NAME: POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; SODIUM SULFATE ANHYDROUS
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]
ROUTE: ORAL
DOSAGE FORM: POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2009-06-01
END MARKETING DATE: 0000-00-00


Polyethylene Glycol-3350 and Electrolytes with Flavor Pack HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPolyethylene Glycol-3350 and Electrolytes with Flavor Pack from Novel Laboratories, Inc.
LABELER NAME: Novel Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 240; 5.84; 6.72; 2.98; 22.72(g/278.26g; g/278.26g; g/278.26g; g/278.26g; g/278.26g)
START MARKETING DATE: 2009-06-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 40032-060_b76cfbc2-2ecf-478c-adae-a141ec93553d
PRODUCT NDC: 40032-060
APPLICATION NUMBER: ANDA090186

Other POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; SODIUM SULFATE ANHYDROUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
GAVIS Pharmaceuticals, LLCGaviLyte – C
Novel Laboratories, Inc.Polyethylene Glycol-3350 and Electrolytes with Flavor Pack